SIRT7 Exhibits Oncogenic Potential in Human Ovarian Cancer Cells |
Wang, Hong-Ling
(Department of Clinical Laboratory, Fudan University Shanghai Cancer Center)
Lu, Ren-Quan (Department of Clinical Laboratory, Fudan University Shanghai Cancer Center) Xie, Su-Hong (Department of Clinical Laboratory, Fudan University Shanghai Cancer Center) Zheng, Hui (Department of Clinical Laboratory, Fudan University Shanghai Cancer Center) Wen, Xue-Mei (Department of Clinical Laboratory, Fudan University Shanghai Cancer Center) Gao, Xiang (Department of Clinical Laboratory, Fudan University Shanghai Cancer Center) Guo, Lin (Department of Clinical Laboratory, Fudan University Shanghai Cancer Center) |
1 | Alvero AB (2010). Recent insights into the role of NF-kappaB in ovarian carcinogenesis. Genome Med, 2, 56. DOI |
2 | Ashraf N, Zino S, Macintyre A, et al (2006). Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer, 95, 1056-61. DOI |
3 | Barber MF, Michishita-Kioi E, Xi Y, et al (2012). SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature, 487, 114-8. |
4 | Blander G, Guarente L (2004). The Sir2 family of protein deacetylases. Annu Rev Biochem, 73, 417-35. DOI |
5 | Bosch-Presegue L, Vaquero A (2011). The dual role of sirtuins in cancer. Genes Cancer, 2, 648-662. DOI |
6 | Chen WT, Gao X, Han XD, et al (2014). HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer. Asian Pac J Cancer Prev, 15, 101-5. DOI |
7 | Ford E, Voit R, Liszt G, et al (2006). Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev, 20, 1075-80. DOI |
8 | Han Y, Liu Y, Zhang H, et al (2013). Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1. FEBS Lett, 587, 3875-82. DOI |
9 | Jemal A, Murray T, Samuels A, et al (2003). Cancer statistics, 2003. CA Cancer J Clin, 53, 5-26. DOI |
10 | Kim JK, Noh JH, Jung KH, et al (2013). Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology, 57, 1055-67. DOI ScienceOn |
11 | Lai CC, Lin PM, Lin SF, et al (2013). Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol, 34, 1847-54. DOI ScienceOn |
12 | Lavu S, Boss O, Elliott PJ, et al (2008). Sirtuins--novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov, 7, 841-53. DOI |
13 | North BJ, Verdin E (2004). Sirtuins: Sir2-related NADdependent protein deacetylases. Genome Biol, 5, 224. DOI |
14 | Shin J, He M, Liu Y, et al (2013). SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Rep, 5, 654-65. DOI |
15 | Yu H, Ye W, Wu J, et al (2014). Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin Cancer Res, 20, 3434-45. DOI |
16 | Tsai YC, Greco TM, Boonmee A, et al (2012). Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol Cell Proteomics, 11, 60-76. DOI |
17 | Vakhrusheva O, Smolka C, Gajawada P, et al (2008). Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res, 102, 703-10. DOI |